Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS-FANTASIO study).

Barre T, Marcellin F, Di Beo V, Delorme J, Rojas Rojas T, Mathurin P, Protopopescu C, Bailly F, Coste M, Authier N, Carrieri MP, Rolland B.

Addiction. 2019 Oct 8. doi: 10.1111/add.14820. [Epub ahead of print]

PMID:
31595554
2.

Prevention and care of hepatitis B in the rural region of Fatick in Senegal: a healthcare workers' perspective using a mixed methods approach.

Djaogol T, Coste M, Marcellin F, Jaquet A, Chabrol F, Giles-Vernick T, Diallo A, Carrieri MP, Boyer S; ANRS 12356 AmBASS Study Group.

BMC Health Serv Res. 2019 Sep 4;19(1):627. doi: 10.1186/s12913-019-4416-3.

3.

Elevated fatty liver index as a risk factor for all-cause mortality in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study).

Barré T, Protopopescu C, Bani-Sadr F, Piroth L, Rojas Rojas T, Salmon-Ceron D, Wittkop L, Esterle L, Sogni P, Lacombe K, Chas J, Zaegel O, Chaix ML, Miailhes P, Serfaty L, Marcellin F, Carrieri MP; ANRS CO13 HEPAVIH Study Group.

Hepatology. 2019 Aug 29. doi: 10.1002/hep.30914. [Epub ahead of print]

PMID:
31466125
4.

France removes hepatitis C treatment prescriber restrictions-But what is the impact of the delay for key populations?

Marcellin F, Roux P, Lazarus JV, Rolland B, Carrieri P.

Liver Int. 2019 Aug 22. doi: 10.1111/liv.14208. [Epub ahead of print] No abstract available.

PMID:
31436366
5.

Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356).

Coste M, De Sèze M, Diallo A, Carrieri MP, Marcellin F, Boyer S; ANRS 12356 AmBASS Study Group.

BMJ Open. 2019 Jul 17;9(7):e030211. doi: 10.1136/bmjopen-2019-030211.

6.

HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort).

Santos ME, Protopopescu C, Sogni P, Yaya I, Piroth L, Bailly F, Marcellin F, Esterle L, Wittkop L, Rosenthal E, Morlat P, Roux P, de Araujo WN, Salmon-Ceron D, Carrieri MP; ANRS CO13 HEPAVIH Study Group.

AIDS Behav. 2019 Jul 8. doi: 10.1007/s10461-019-02585-7. [Epub ahead of print]

PMID:
31286317
7.

Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project.

Rojas Rojas T, Di Beo V, Delorme J, Barre T, Mathurin P, Protopopescu C, Bailly F, Coste M, Authier N, Carrieri MP, Rolland B, Marcellin F.

Int J Drug Policy. 2019 Oct;72:61-68. doi: 10.1016/j.drugpo.2019.05.013. Epub 2019 May 22.

PMID:
31129024
8.

Sleep disturbances in HIV-HCV coinfected patients: indications for clinical management in the HCV cure era (ANRS CO13 HEPAVIH cohort).

Costa M, Rojas Rojas T, Lacoste D, Villes V, Aumaitre H, Protopopescu C, Yaya I, Wittkop L, Krause J, Salmon-Céron D, Marcellin F, Sogni P, Carrieri MP; ANRS CO13 HEPAVIH Study Group.

Eur J Gastroenterol Hepatol. 2019 May 14. doi: 10.1097/MEG.0000000000001441. [Epub ahead of print]

PMID:
31094856
9.

No influence of cannabis use on liver stiffness in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study).

Marcellin F, Protopopescu C, Wittkop L, Salmon-Ceron D, Sogni P, Carrieri MP; ANRS CO13 HEPAVIH Study Group.

Eur J Gastroenterol Hepatol. 2019 Feb;31(2):274-276. doi: 10.1097/MEG.0000000000001301. No abstract available.

PMID:
30575641
10.

Letter to the Editor: Patient-Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use.

Carrieri P, Duracinsky M, Marcellin F, Lazarus JV.

Hepatology. 2019 Jul;70(1):443-444. doi: 10.1002/hep.30356. No abstract available.

PMID:
30472796
11.

Wine Consumption and Lower Risk of Advanced Liver Fibrosis: A True Effect or Unmeasured Confounding? A Longitudinal Analysis (ANRS CO13 HEPAVIH Cohort).

Marcellin F, Costa M, Wittkop L, Protopopescu C, Esterle L, Salmon-Ceron D, Sogni P, Carrieri MP; ANRS CO13 HEPAVIH Study Group.

Am J Gastroenterol. 2018 Nov;113(11):1729-1732. doi: 10.1038/s41395-018-0270-x. No abstract available.

PMID:
30333544
12.

Access to care for people with alcohol use disorder in France: a mixed-method cross-sectional study protocol (ASIA).

Costa M, Marcellin F, Coste M, Barré T, Nordmann S, Mora M, Maradan G, Tanti M, Cutarella C, Casanova D, Levy-Bellaiche S, Polomeni P, Simon N, Roux P, Carrieri MP.

BMJ Open. 2018 Sep 28;8(9):e024669. doi: 10.1136/bmjopen-2018-024669.

13.

Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.

Yaya I, Roux P, Marcellin F, Wittkop L, Esterle L, Spire B, Dominguez S, Elegbe BA, Piroth L, Sogni P, Salmon-Ceron D, Carrieri MP; ANRS CO13 HEPAVIH Study Group.

PLoS One. 2018 Jul 5;13(7):e0199874. doi: 10.1371/journal.pone.0199874. eCollection 2018.

14.

Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS HEPAVIH CO-13 Cohort).

Yaya I, Marcellin F, Costa M, Morlat P, Protopopescu C, Pialoux G, Santos ME, Wittkop L, Esterle L, Gervais A, Sogni P, Salmon-Ceron D, Carrieri MP; ANRS CO13-HEPAVIH Cohort Study Group.

Nutrients. 2018 May 31;10(6). pii: E705. doi: 10.3390/nu10060705.

15.

Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research.

Marcellin F, Fontaine H, Serfaty L, Sogni P, Carrieri MP.

Expert Rev Anti Infect Ther. 2018 May;16(5):377-380. doi: 10.1080/14787210.2018.1473764. Epub 2018 May 8. No abstract available.

PMID:
29737223
16.

Posttraumatic Stress Disorder as a Significant Correlate of Voluntary Antiretroviral Treatment Interruption in Adult HIV-Infected Patients Followed up in French Hospitals: Data From the ANRS-VESPA2 National Survey.

Roux P, Marcellin F, Ndiaye K, Suzan-Monti M, Mayet A, Duracinsky M, Briand-Madrid L, Maradan G, Mora M, Préau M, Verger P, Carrieri P, Dray-Spira R, Spire B; ANRS-VESPA2 Study Group.

J Clin Psychiatry. 2018 May/Jun;79(3). pii: 17m11659. doi: 10.4088/JCP.17m11659.

PMID:
29659208
17.

Reply to: "Coffee consumption and decreased all-cause mortality - What is the true estimate of effect?"

Protopopescu C, Marcellin F, Salmon-Ceron D, Carrieri MP.

J Hepatol. 2018 May;68(5):1106. doi: 10.1016/j.jhep.2018.01.032. Epub 2018 Feb 8. No abstract available.

PMID:
29427730
18.

Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).

Rosenthal E, Fougerou-Leurent C, Renault A, Carrieri MP, Marcellin F, Garraffo R, Teicher E, Aumaitre H, Lacombe K, Bailly F, Billaud E, Chevaliez S, Dominguez S, Valantin MA, Reynes J, Naqvi A, Cotte L, Metivier S, Leroy V, Dupon M, Allegre T, De Truchis P, Jeantils V, Chas J, Salmon-Ceron D, Morlat P, Neau D, Perré P, Piroth L, Pol S, Bourlière M, Pageaux GP, Alric L, Zucman D, Girard PM, Poizot-Martin I, Yazdanpanah Y, Raffi F, Pabic EL, Tual C, Pailhé A, Amri I, Bellissant E, Molina JM; ANRS HC31 SOFTRIH Study Group.

HIV Med. 2018 Mar;19(3):227-237. doi: 10.1111/hiv.12571. Epub 2017 Dec 7.

PMID:
29214737
19.

The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients.

Carrieri MP, Protopopescu C, Marcellin F, Wittkop L, Lacombe K, Esterle L, Sogni P, Salmon-Ceron D; ANRS CO13 HEPAVIH Study Group.

J Hepatol. 2018 Apr;68(4):845-847. doi: 10.1016/j.jhep.2017.10.025. Epub 2017 Nov 2. No abstract available.

PMID:
29104123
20.

Gender, Alcohol Use, and Fibrosis in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Individuals.

Yaya I, Costa M, Marcellin F, Miailhes P, Wittkop L, Salmon-Ceron D, Carrieri MP; Agence Nationale de Recherches sur le Sida et les Hépatites virales B et C (ANRS) CO13 HEPAVIH (hepatitis + VIH [= HIV in French]) Study Group.

Clin Infect Dis. 2018 Mar 5;66(6):983-984. doi: 10.1093/cid/cix927. No abstract available.

PMID:
29088334
21.

Impaired patient-reported outcomes persist in HIV-HCV co-infected patients and in cirrhotic patients despite HCV clearance.

Marcellin F, Morlat P, Wittkop L, Salmon-Ceron D, Carrieri MP.

J Viral Hepat. 2018 Mar;25(3):314-315. doi: 10.1111/jvh.12811. Epub 2017 Nov 20. No abstract available.

PMID:
29080244
22.

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH).

Nordmann S, Vilotitch A, Roux P, Esterle L, Spire B, Marcellin F, Salmon-Ceron D, Dabis F, Chas J, Rey D, Wittkop L, Sogni P, Carrieri P; ANRS CO13 HEPAVIH Study Group.

J Viral Hepat. 2018 Feb;25(2):171-179. doi: 10.1111/jvh.12797. Epub 2017 Nov 20.

PMID:
28984055
23.

Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients.

Carrieri MP, Protopopescu C, Marcellin F, Rosellini S, Wittkop L, Esterle L, Zucman D, Raffi F, Rosenthal E, Poizot-Martin I, Salmon-Ceron D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group.

J Hepatol. 2017 Dec;67(6):1157-1167. doi: 10.1016/j.jhep.2017.08.005. Epub 2017 Sep 21.

PMID:
28942916
24.

Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).

Yaya I, Roux P, Marcellin F, Salmon-Ceron D, Carrieri MP.

Dig Dis Sci. 2017 Oct;62(10):2943-2944. doi: 10.1007/s10620-017-4703-y. Epub 2017 Aug 5. No abstract available.

PMID:
28780609
25.

Self-Reported Bothersome Symptoms Across Different Socioepidemiological Groups of People Living With HIV Attending French Hospitals: Results From the ANRS-VESPA2 Survey.

Boyer V, Vilotitch A, Marcellin F, Demoulin B, Dray-Spira R, Spire B; ANRS-VESPA2 Study Group.

J Pain Symptom Manage. 2017 Jul;54(1):110-119. doi: 10.1016/j.jpainsymman.2017.03.010. Epub 2017 May 4.

PMID:
28479413
26.

Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.

Knight R, Roux P, Vilotitch A, Marcellin F, Rosenthal E, Esterle L, Boué F, Rey D, Piroth L, Dominguez S, Sogni P, Salmon-Ceron D, Spire B, Carrieri MP; ANRS CO13-HEPAVIH Study Group.

Addiction. 2017 Sep;112(9):1669-1679. doi: 10.1111/add.13851. Epub 2017 Jun 6.

PMID:
28430385
27.

Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).

Marcellin F, Protopopescu C, Esterle L, Wittkop L, Piroth L, Aumaitre H, Bouchaud O, Goujard C, Vittecoq D, Dabis F, Salmon-Ceron D, Spire B, Roux P, Carrieri MP; ANRS CO13-HEPAVIH Study Group.

Eur J Gastroenterol Hepatol. 2017 Jul;29(7):786-791. doi: 10.1097/MEG.0000000000000883.

PMID:
28418984
28.

Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).

Carrieri MP, Protopopescu C, Younossi Z, Vilotitch A, Fontaine H, Petrov-Sanchez V, Marcellin F, Carrat F, Hézode C, Bourlière M; CUPIC Study Group.

Patient. 2017 Oct;10(5):605-614. doi: 10.1007/s40271-017-0232-1.

PMID:
28353221
29.

Suicide risk in a representative sample of people receiving HIV care: Time to target most-at-risk populations (ANRS VESPA2 French national survey).

Carrieri MP, Marcellin F, Fressard L, Préau M, Sagaon-Teyssier L, Suzan-Monti M, Guagliardo V, Mora M, Roux P, Dray-Spira R, Spire B; ANRS-VESPA2 Study Group.

PLoS One. 2017 Feb 13;12(2):e0171645. doi: 10.1371/journal.pone.0171645. eCollection 2017.

30.

Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues.

Marcellin F, Roux P, Protopopescu C, Duracinsky M, Spire B, Carrieri MP.

Expert Rev Gastroenterol Hepatol. 2017 Mar;11(3):259-268. doi: 10.1080/17474124.2017.1285227. Epub 2017 Jan 31. Review.

PMID:
28116926
31.

Disclosure of HIV Status Beyond Sexual Partners by People Living with HIV in France: A Call for Help? Results from the National Cross-Sectional Survey ANRS-VESPA2.

Marcellin F, Suzan-Monti M, Vilotitch A, Sagaon-Teyssier L, Mora M, Dray-Spira R, Préau M, Lert F, Spire B; ANRS VESPA2 Study Group.

AIDS Behav. 2017 Jan;21(1):196-206. doi: 10.1007/s10461-016-1549-9.

PMID:
27614877
32.

Heterosexual practices of women and men living with HIV attending hospital outpatient services (ANRS-VESPA2 survey): a French comparative study with the general population (CSF survey).

Boyer V, Vilotitch A, Panjo H, Sagaon-Teyssier L, Marcellin F, Dray-Spira R, Spire B, Bajos N.

AIDS Care. 2016 Nov;28(11):1345-54. doi: 10.1080/09540121.2016.1191600. Epub 2016 Jun 7.

PMID:
27267205
33.

Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).

Marcellin F, Protopopescu C, Poizot-Martin I, Miailhes P, Esterle L, Wittkop L, Spire B, Bocquier A, Salmon-Ceron D, Dabis F, Carrieri MP; HEPAVIH ANRS CO13 Study Group.

Eur J Gastroenterol Hepatol. 2016 Sep;28(9):1003-7. doi: 10.1097/MEG.0000000000000664.

PMID:
27177169
34.

From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials).

Marcellin F, Fournier I, Carrieri MP, Poizot-Martin I, Cotte L; ANRS HC26 & ANRS HC27 Study Groups.

Eur J Gastroenterol Hepatol. 2016 Jun;28(6):733-4. doi: 10.1097/MEG.0000000000000612. No abstract available.

PMID:
27111390
35.

No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).

Marcellin F, Lions C, Rosenthal E, Roux P, Sogni P, Wittkop L, Protopopescu C, Spire B, Salmon-Ceron D, Dabis F, Carrieri MP; HEPAVIH ANRS CO13 Study Group*.

Drug Alcohol Rev. 2017 Mar;36(2):227-238. doi: 10.1111/dar.12398. Epub 2016 Apr 13.

PMID:
27073179
36.

Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).

Roux P, Lions C, Vilotitch A, Michel L, Mora M, Maradan G, Marcellin F, Spire B, Morel A, Carrieri PM; ANRS Methaville study group.

Harm Reduct J. 2016 Apr 5;13:12. doi: 10.1186/s12954-016-0100-7.

37.

Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey.

Suzan-Monti M, Lorente N, Demoulin B, Marcellin F, Préau M, Dray-Spira R, Lert F, Spire B; ANRS-VESPA2 Study Group.

J Int AIDS Soc. 2016 Jan 8;19(1):20095. doi: 10.7448/IAS.19.1.20095. eCollection 2016.

38.

Risk Factors for HCV Reinfection or Transmission in HIV-HCV Coinfected MSM (ANRS-VESPA2 French National Survey).

Marcellin F, Demoulin B, Suzan-Monti M, Maradan G, Carrieri MP, Dray-Spira R, Spire B; ANRS-VESPA2 Study Group.

J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):e179-82. doi: 10.1097/QAI.0000000000000836. No abstract available.

PMID:
26569181
39.

A reduced factor structure for the PROQOL-HIV questionnaire provided reliable indicators of health-related quality of life.

Lalanne C, Chassany O, Carrieri P, Marcellin F, Armstrong AR, Lert F, Spire B, Dray-Spira R, Duracinsky M.

J Clin Epidemiol. 2016 Apr;72:116-25. doi: 10.1016/j.jclinepi.2015.10.009. Epub 2015 Nov 5.

PMID:
26548542
40.

Suicidal risk among patients enrolled in methadone maintenance treatment: HCV status and implications for suicide prevention (ANRS Methaville).

Michel L, Lions C, Maradan G, Mora M, Marcellin F, Morel A, Spire B, Roux P, Carrieri PM; Methaville Study Group.

Compr Psychiatry. 2015 Oct;62:123-31. doi: 10.1016/j.comppsych.2015.07.004. Epub 2015 Jul 14.

PMID:
26343476
41.

Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).

Marcellin F, Demoulin B, Spire B, Suzan-Monti M, Roux P, Protopopescu C, Sagaon-Teyssier L, Duracinsky M, Dray-Spira R, Carrieri MP; ANRS-VESPA2 Study Group.

Expert Rev Gastroenterol Hepatol. 2015 May;9(5):701-13. doi: 10.1586/17474124.2015.1016914. Epub 2015 Feb 27.

PMID:
25723557
42.

Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville).

Carrieri PM, Michel L, Lions C, Cohen J, Vray M, Mora M, Marcellin F, Spire B, Morel A, Roux P; Methaville Study Group.

PLoS One. 2014 Nov 13;9(11):e112328. doi: 10.1371/journal.pone.0112328. eCollection 2014.

43.

Confirmation of the Factor Structure of the Proqol-HIV Questionnaire to Assess Health-Related Quality of Life in PLWHA.

Lalanne C, Duracinsky M, Marcellin F, Lert F, Chassany O, Carrieri PM, Dray-Spira R, Spire B.

Value Health. 2014 Nov;17(7):A681-2. doi: 10.1016/j.jval.2014.08.2542. Epub 2014 Oct 26. No abstract available.

44.

Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions.

Roux P, Lions C, Michel L, Mora M, Daulouède JP, Marcellin F, Spire B, Morel A, Carrieri PM; ANRS Methaville study group.

Subst Abuse Treat Prev Policy. 2014 Sep 10;9:37. doi: 10.1186/1747-597X-9-37.

45.

Comparison of risk factors in HIV-infected men who have sex with men, coinfected or not with hepatitis C virus (ANRS VESPA2 French cross-sectional national survey).

Marcellin F, Lorente N, Demoulin B, Carrieri MP, Suzan-Monti M, Roux P, Lert F, Sagaon-Teyssier L, Dray-Spira R, Spire B; ANRS VESPA2 Study Group.

Sex Transm Infect. 2015 Feb;91(1):21-3. doi: 10.1136/sextrans-2014-051542. Epub 2014 Aug 5.

PMID:
25096920
46.

High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort.

Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP; HEPAVIH (ANRS CO13) Study Group.

Clin Infect Dis. 2014 Oct 15;59(8):1190-2. doi: 10.1093/cid/ciu525. Epub 2014 Jul 11. No abstract available.

PMID:
25015913
47.

Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys).

Douab T, Marcellin F, Vilotitch A, Protopopescu C, Préau M, Suzan-Monti M, Sagaon-Teyssier L, Lert F, Carrieri MP, Dray-Spira R, Spire B; ANRS-VESPA2 Study Group.

AIDS Care. 2014;26 Suppl 1:S29-40. doi: 10.1080/09540121.2014.906553. Epub 2014 Apr 14.

PMID:
24731158
48.

Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.

Marcellin F, Roux P, Winnock M, Lions C, Dabis F, Salmon-Ceron D, Loko MA, Spire B, Carrieri MP.

Expert Rev Gastroenterol Hepatol. 2014 May;8(4):351-8. doi: 10.1586/17474124.2014.888949. Epub 2014 Mar 3. Review.

PMID:
24580042
49.

Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial).

Lions C, Carrieri MP, Michel L, Mora M, Marcellin F, Morel A, Spire B, Roux P; Methaville Study Group.

Drug Alcohol Depend. 2014 Feb 1;135:1-8. doi: 10.1016/j.drugalcdep.2013.10.018. Epub 2013 Oct 31.

PMID:
24268548
50.

Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: implications for clinicians.

Roux P, Lions C, Michel L, Cohen J, Mora M, Marcellin F, Spire B, Morel A, Carrieri PM, Karila L; ANRS Methaville Study Group.

Curr Pharm Des. 2014;20(25):4097-105.

PMID:
24001291

Supplemental Content

Loading ...
Support Center